{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T05:53:03Z","timestamp":1773985983765,"version":"3.50.1"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s10555-015-9574-0","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T01:51:31Z","timestamp":1438134691000},"page":"401-416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Clinical translation for endometrial cancer stem cells hypothesis"],"prefix":"10.1007","volume":"34","author":[{"given":"Maria Jo\u00e3o","family":"Carvalho","sequence":"first","affiliation":[]},{"given":"Mafalda","family":"Laranjo","sequence":"additional","affiliation":[]},{"given":"Ana Margarida","family":"Abrantes","sequence":"additional","affiliation":[]},{"given":"Isabel","family":"Torgal","sequence":"additional","affiliation":[]},{"given":"Maria Filomena","family":"Botelho","sequence":"additional","affiliation":[]},{"given":"Carlos Freire","family":"Oliveira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,7,30]]},"reference":[{"key":"9574_CR1","doi-asserted-by":"crossref","unstructured":"Colombo, N., Preti, E., Landoni, F., Carinelli, S., Colombo, a, Marini, C., Sessa, C. (2011). Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology\/ ESMO, 22 Suppl 6(Supplement 6), vi35\u20139. doi: 10.1093\/annonc\/mdr374","DOI":"10.1093\/annonc\/mdr374"},{"issue":"2","key":"9574_CR2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ygyno.2014.05.018","volume":"134","author":"WM Burke","year":"2014","unstructured":"Burke, W. M., Orr, J., Leitao, M., Salom, E., Gehrig, P., Olawaiye, A. B., & Abu Shahin, F. (2014). Endometrial cancer: a review and current management strategies: part I. Gynecologic Oncology, 134(2), 385\u2013392. doi: 10.1016\/j.ygyno.2014.05.018 .","journal-title":"Gynecologic Oncology"},{"issue":"2","key":"9574_CR3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/cyt.12131","volume":"25","author":"M Fambrini","year":"2014","unstructured":"Fambrini, M., Sorbi, F., Sisti, G., Cioni, R., Turrini, I., Taddei, G., & Guaschino, S. (2014). Endometrial carcinoma in high-risk populations: is it time to consider a screening policy? Cytopathology, 25(2), 71\u201377. doi: 10.1111\/cyt.12131 .","journal-title":"Cytopathology"},{"issue":"9","key":"9574_CR4","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.ejca.2014.02.020","volume":"50","author":"E Weiderpass","year":"2014","unstructured":"Weiderpass, E., Antoine, J., Bray, F. I., Oh, J. K., & Arbyn, M. (2014). Trends in corpus uteri cancer mortality in member states of the European Union. European Journal of Cancer, 50(9), 1675\u20131684. doi: 10.1016\/j.ejca.2014.02.020 .","journal-title":"European Journal of Cancer"},{"issue":"7","key":"9574_CR5","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1016\/S1470-2045(13)70591-6","volume":"15","author":"R Murali","year":"2014","unstructured":"Murali, R., Soslow, R. A., & Weigelt, B. (2014). Classification of endometrial carcinoma: more than two types. The Lancet Oncology, 15(7), e268\u201378. doi: 10.1016\/S1470-2045(13)70591-6 .","journal-title":"The Lancet Oncology"},{"issue":"15","key":"9574_CR6","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/jnci\/89.15.1110","volume":"89","author":"MC Pike","year":"1997","unstructured":"Pike, M. C., Peters, R. K., Cozen, W., Probst-Hensch, N. M., Wan, P. C., Mack, T. M., & Felix, J. C. (1997). Estrogen-progestin replacement therapy and endometrial cancer. Journal of the National Cancer Institute, 89(15), 1110\u20131116. doi: 10.1093\/jnci\/89.15.1110 .","journal-title":"Journal of the National Cancer Institute"},{"issue":"11","key":"9574_CR7","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1002\/cncr.21866","volume":"106","author":"PT Soliman","year":"2006","unstructured":"Soliman, P. T., Wu, D., Tortolero-Luna, G., Schmeler, K. M., Slomovitz, B. M., Bray, M. S., & Lu, K. H. (2006). Association between adiponectin, insulin resistance, and endometrial cancer. Cancer, 106(11), 2376\u20132381. doi: 10.1002\/cncr.21866 .","journal-title":"Cancer"},{"issue":"7","key":"9574_CR8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jnci\/86.7.527","volume":"86","author":"B Fisher","year":"1994","unstructured":"Fisher, B., Costantino, J. P., Redmond, C. K., Fisher, E. R., Wickerham, D. L., & Cronin, W. M. (1994). Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. Journal of the National Cancer Institute, 86(7), 527\u2013537. doi: 10.1093\/jnci\/86.7.527 .","journal-title":"Journal of the National Cancer Institute"},{"issue":"6","key":"9574_CR9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.amjmed.2008.01.044","volume":"121","author":"B Zhou","year":"2008","unstructured":"Zhou, B., Yang, L., Sun, Q., Cong, R., Gu, H., Tang, N., & Wang, B. (2008). Cigarette smoking and the risk of endometrial cancer: a meta-analysis. The American journal of medicine, 121(6), 501\u2013508.e3. doi: 10.1016\/j.amjmed.2008.01.044 .","journal-title":"The American journal of medicine"},{"issue":"1","key":"9574_CR10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/AOG.0b013e3181e3e7e8","volume":"116","author":"A Timmermans","year":"2010","unstructured":"Timmermans, A., Opmeer, B. C., Khan, K. S., Bachmann, L. M., Epstein, E., Clark, T. J., & Mol, B. W. J. (2010). Endometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: a systematic review and meta-analysis. Obstetrics and Gynecology, 116(1), 160\u2013167. doi: 10.1097\/AOG.0b013e3181e3e7e8 .","journal-title":"Obstetrics and Gynecology"},{"issue":"1","key":"9574_CR11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","volume":"15","author":"JV Bokhman","year":"1983","unstructured":"Bokhman, J. V. (1983). Two pathogenetic types of endometrial carcinoma. Gynecologic Oncology, 15(1), 10\u201317.","journal-title":"Gynecologic Oncology"},{"issue":"3","key":"9574_CR12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1053\/j.semdp.2014.03.002","volume":"31","author":"S Chiang","year":"2014","unstructured":"Chiang, S., & Soslow, R. A. (2014). Updates in diagnostic immunohistochemistry in endometrial carcinoma. Seminars in Diagnostic Pathology, 31(3), 205\u2013215. doi: 10.1053\/j.semdp.2014.03.002 .","journal-title":"Seminars in Diagnostic Pathology"},{"issue":"3","key":"9574_CR13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1006\/gyno.1998.5208","volume":"71","author":"SB Simpkins","year":"1998","unstructured":"Simpkins, S. B., Peiffer-Schneider, S., Mutch, D. G., Gersell, D., & Goodfellow, P. J. (1998). PTEN mutations in endometrial cancers with 10q LOH: additional evidence for the involvement of multiple tumor suppressors. Gynecologic Oncology, 71(3), 391\u2013395. doi: 10.1006\/gyno.1998.5208 .","journal-title":"Gynecologic Oncology"},{"issue":"12","key":"9574_CR14","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1097\/00000478-200412000-00004","volume":"28","author":"F Darvishian","year":"2004","unstructured":"Darvishian, F., Hummer, A. J., Thaler, H. T., Bhargava, R., Linkov, I., Asher, M., & Soslow, R. A. (2004). Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases. The American Journal of Surgical Pathology, 28(12), 1568\u20131578.","journal-title":"The American Journal of Surgical Pathology"},{"issue":"2","key":"9574_CR15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.mce.2011.10.003","volume":"358","author":"M Llaurad\u00f3","year":"2012","unstructured":"Llaurad\u00f3, M., Ruiz, A., Majem, B., Ertekin, T., Col\u00e1s, E., Pedrola, N., & Revent\u00f3s, J. (2012). Molecular bases of endometrial cancer: new roles for new actors in the diagnosis and the therapy of the disease. Molecular and Cellular Endocrinology, 358(2), 244\u2013255. doi: 10.1016\/j.mce.2011.10.003 .","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"1","key":"9574_CR16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00428-010-0939-z","volume":"457","author":"GF Zannoni","year":"2010","unstructured":"Zannoni, G. F., Vellone, V. G., Arena, V., Prisco, M. G., Scambia, G., Carbone, A., & Gallo, D. (2010). Does high-grade endometrioid carcinoma (grade 3 FIGO) belong to type I or type II endometrial cancer? A clinical-pathological and immunohistochemical study. Virchows Archiv, 457(1), 27\u201334. doi: 10.1007\/s00428-010-0939-z .","journal-title":"Virchows Archiv"},{"issue":"7","key":"9574_CR17","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.humpath.2006.12.018","volume":"38","author":"S Yamamoto","year":"2007","unstructured":"Yamamoto, S., Tsuda, H., Aida, S., Shimazaki, H., Tamai, S., & Matsubara, O. (2007). Immunohistochemical detection of hepatocyte nuclear factor 1beta in ovarian and endometrial clear-cell adenocarcinomas and nonneoplastic endometrium. Human Pathology, 38(7), 1074\u20131080. doi: 10.1016\/j.humpath.2006.12.018 .","journal-title":"Human Pathology"},{"issue":"4","key":"9574_CR18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/path.1310","volume":"199","author":"G Moreno-Bueno","year":"2003","unstructured":"Moreno-Bueno, G., Hardisson, D., Sarri\u00f3, D., S\u00e1nchez, C., Cassia, R., Prat, J., & Palacios, J. (2003). Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia. The Journal of Pathology, 199(4), 471\u2013478. doi: 10.1002\/path.1310 .","journal-title":"The Journal of Pathology"},{"issue":"10","key":"9574_CR19","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/01.MP.0000028573.34289.04","volume":"15","author":"PW Schlosshauer","year":"2002","unstructured":"Schlosshauer, P. W., Ellenson, L. H., & Soslow, R. A. (2002). Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype. Modern Pathology, 15(10), 1032\u20131037. doi: 10.1097\/01.MP.0000028573.34289.04 .","journal-title":"Modern Pathology"},{"issue":"2","key":"9574_CR20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1158\/2159-8290.CD-11-0039","volume":"1","author":"LWT Cheung","year":"2011","unstructured":"Cheung, L. W. T., Hennessy, B. T., Li, J., Yu, S., Myers, A. P., Djordjevic, B., & Mills, G. B. (2011). High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability. Cancer Discovery, 1(2), 170\u2013185. doi: 10.1158\/2159-8290.CD-11-0039 .","journal-title":"Cancer Discovery"},{"key":"9574_CR21","author":"MK McConechy","year":"2012","unstructured":"McConechy, M. K., Ding, J., Cheang, M. C. U., Wiegand, K. C., Senz, J., Tone, A. A., & Huntsman, D. G. (2012). Use of mutation profiles to refine the classification of endometrial carcinomas. Journal of Pathology. doi: 10.1002\/path.4056 .","journal-title":"Journal of Pathology"},{"issue":"1","key":"9574_CR22","first-page":"177","volume":"150","author":"H Tashiro","year":"1997","unstructured":"Tashiro, H., Isacson, C., Levine, R., Kurman, R. J., Cho, K. R., & Hedrick, L. (1997). p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. The American Journal of Pathology, 150(1), 177\u2013185.","journal-title":"The American Journal of Pathology"},{"issue":"8","key":"9574_CR23","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1158\/1078-0432.CCR-07-4837","volume":"14","author":"L Jia","year":"2008","unstructured":"Jia, L., Liu, Y., Yi, X., Miron, A., Crum, C. P., Kong, B., & Zheng, W. (2008). Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma. Clinical Cancer Research, 14(8), 2263\u20132269. doi: 10.1158\/1078-0432.CCR-07-4837 .","journal-title":"Clinical Cancer Research"},{"key":"9574_CR24","doi-asserted-by":"crossref","unstructured":"Network, C. G. A. R., Institute, G. sequencing centres: B., Getz, G., Gabriel, S. B., Cibulskis, K., Lander, E., \u2026 Committee, W. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67\u201373. doi: 10.1038\/nature12113","DOI":"10.1038\/nature12113"},{"issue":"11","key":"9574_CR25","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/molehr\/gaq061","volume":"16","author":"CE Gargett","year":"2010","unstructured":"Gargett, C. E., & Masuda, H. (2010). Adult stem cells in the endometrium. Molecular Human Reproduction, 16(11), 818\u2013834. doi: 10.1093\/molehr\/gaq061 .","journal-title":"Molecular Human Reproduction"},{"issue":"1-2","key":"9574_CR26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mce.2008.02.026","volume":"288","author":"CE Gargett","year":"2008","unstructured":"Gargett, C. E., Chan, R. W. S., & Schwab, K. E. (2008). Hormone and growth factor signaling in endometrial renewal: role of stem\/progenitor cells. Molecular and Cellular Endocrinology, 288(1-2), 22\u201329. doi: 10.1016\/j.mce.2008.02.026 .","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"3","key":"9574_CR27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/rep.0.1250301","volume":"125","author":"LA Salamonsen","year":"2003","unstructured":"Salamonsen, L. A. (2003). Tissue injury and repair in the female human reproductive tract. Reproduction, 125(3), 301\u2013311. doi: 10.1530\/rep.0.1250301 .","journal-title":"Reproduction"},{"issue":"3","key":"9574_CR28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/humupd\/dmg019","volume":"9","author":"LC Giudice","year":"2003","unstructured":"Giudice, L. C. (2003). Elucidating endometrial function in the post-genomic era. Human Reproduction Update, 9(3), 223\u2013235. doi: 10.1093\/humupd\/dmg019 .","journal-title":"Human Reproduction Update"},{"issue":"6","key":"9574_CR29","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1095\/biolreprod.103.024109","volume":"70","author":"RWS Chan","year":"2004","unstructured":"Chan, R. W. S., Schwab, K. E., & Gargett, C. E. (2004). Clonogenicity of human endometrial epithelial and stromal cells. Biology of Reproduction, 70(6), 1738\u20131750. doi: 10.1095\/biolreprod.103.024109 .","journal-title":"Biology of Reproduction"},{"issue":"5","key":"9574_CR30","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/humrep\/del514","volume":"22","author":"K Kato","year":"2007","unstructured":"Kato, K., Yoshimoto, M., Kato, K., Adachi, S., Yamayoshi, A., Arima, T., & Wake, N. (2007). Characterization of side-population cells in human normal endometrium. Human Reproduction, 22(5), 1214\u20131223. doi: 10.1093\/humrep\/del514 .","journal-title":"Human Reproduction"},{"issue":"6","key":"9574_CR31","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1634\/stemcells.2005-0411","volume":"24","author":"RWS Chan","year":"2006","unstructured":"Chan, R. W. S., & Gargett, C. E. (2006). Identification of label-retaining cells in mouse endometrium. Stem cells, 24(6), 1529\u20131538. doi: 10.1634\/stemcells.2005-0411 .","journal-title":"Stem cells"},{"issue":"1","key":"9574_CR32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/humrep\/del332","volume":"22","author":"I Cervell\u00f3","year":"2007","unstructured":"Cervell\u00f3, I., Mart\u00ednez-Conejero, J. A., Horcajadas, J. A., Pellicer, A., & Sim\u00f3n, C. (2007). Identification, characterization and co-localization of label-retaining cell population in mouse endometrium with typical undifferentiated markers. Human Reproduction (Oxford, England), 22(1), 45\u201351. doi: 10.1093\/humrep\/del332 .","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"9574_CR33","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/path.2364","volume":"215","author":"M G\u00f6tte","year":"2008","unstructured":"G\u00f6tte, M., Wolf, M., Staebler, A., Buchweitz, O., Kelsch, R., Sch\u00fcring, A. N., & Kiesel, L. (2008). Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma. The Journal of Pathology, 215(3), 317\u2013329. doi: 10.1002\/path.2364 .","journal-title":"The Journal of Pathology"},{"issue":"10","key":"9574_CR34","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrc2499","volume":"8","author":"JE Visvader","year":"2008","unstructured":"Visvader, J. E., & Lindeman, G. J. (2008). Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nature Reviews Cancer, 8(10), 755\u2013768. doi: 10.1038\/nrc2499 .","journal-title":"Nature Reviews Cancer"},{"issue":"9","key":"9574_CR35","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3109\/07357907.2014.958231","volume":"32","author":"A Allegra","year":"2014","unstructured":"Allegra, A., Alonci, A., Penna, G., Innao, V., Gerace, D., Rotondo, F., & Musolino, C. (2014). The cancer stem cell hypothesis: a guide to potential molecular targets. Cancer Investigation, 32(9), 470\u2013495. doi: 10.3109\/07357907.2014.958231 .","journal-title":"Cancer Investigation"},{"issue":"5935","key":"9574_CR36","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1126\/science.1171837","volume":"324","author":"JM Rosen","year":"2009","unstructured":"Rosen, J. M., & Jordan, C. T. (2009). The increasing complexity of the cancer stem cell paradigm. Science, 324(5935), 1670\u20131673.","journal-title":"Science"},{"issue":"1","key":"9574_CR37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1530\/REP-09-0411","volume":"140","author":"SA Hubbard","year":"2010","unstructured":"Hubbard, S. A., & Gargett, C. E. (2010). A cancer stem cell origin for human endometrial carcinoma? Reproduction, 140(1), 23\u201332. doi: 10.1530\/REP-09-0411 .","journal-title":"Reproduction"},{"issue":"3","key":"9574_CR38","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/cr.2012.13","volume":"22","author":"DG Tang","year":"2012","unstructured":"Tang, D. G. (2012). Understanding cancer stem cell heterogeneity and plasticity. Cell Research, 22(3), 457\u2013472. doi: 10.1038\/cr.2012.13 .","journal-title":"Cell Research"},{"issue":"2","key":"9574_CR39","first-page":"157","volume":"65","author":"I Skidan","year":"2014","unstructured":"Skidan, I., & Steiniger, S. (2014). Review article in vivo models for cancer stem cells research: a clinical guide. Jornal of Physiology and Pharmacology, 65(2), 157\u2013169.","journal-title":"Jornal of Physiology and Pharmacology"},{"key":"9574_CR40","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/1471-2407-9-202","volume":"9","author":"E Charafe-Jauffret","year":"2009","unstructured":"Charafe-Jauffret, E., Ginestier, C., & Birnbaum, D. (2009). Breast cancer stem cells: tools and models to rely on. BMC Cancer, 9, 202. doi: 10.1186\/1471-2407-9-202 .","journal-title":"BMC Cancer"},{"key":"9574_CR41","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003). Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America, 100, 3983\u20133988. doi: 10.1073\/pnas.0530291100 .","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"9574_CR42","volume":"3","author":"AP Morel","year":"2008","unstructured":"Morel, A. P., Li\u00e8vre, M., Thomas, C., Hinkal, G., Ansieau, S., & Puisieux, A. (2008). Generation of breast cancer stem cells through epithelial-mesenchymal transition. PloS One, 3(8), e2888. doi: 10.1371\/journal.pone.0002888 .","journal-title":"PloS One"},{"issue":"10","key":"9574_CR43","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1158\/0008-5472.CAN-07-2938","volume":"68","author":"TT Onder","year":"2008","unstructured":"Onder, T. T., Gupta, P. B., Mani, S. A., Yang, J., Lander, E. S., & Weinberg, R. A. (2008). Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Research, 68(10), 3645\u20133654. doi: 10.1158\/0008-5472.CAN-07-2938 .","journal-title":"Cancer Research"},{"key":"9574_CR44","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.cdd.4402283","volume":"15","author":"A Eramo","year":"2008","unstructured":"Eramo, A., Lotti, F., Sette, G., Pilozzi, E., Biffoni, M., Di Virgilio, A., & De Maria, R. (2008). Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death and Differentiation, 15, 504\u2013514. doi: 10.1038\/sj.cdd.4402283 .","journal-title":"Cell Death and Differentiation"},{"issue":"1-2","key":"9574_CR45","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cell.2011.11.050","volume":"148","author":"WC Zhang","year":"2012","unstructured":"Zhang, W. C., Ng, S. C., Yang, H., Rai, A., Umashankar, S., Ma, S., & Lim, B. (2012). Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. Cell, 148(1-2), 259\u2013272. doi: 10.1016\/j.cell.2011.11.050 .","journal-title":"Cell"},{"key":"9574_CR46","unstructured":"Yamashita, T., Ji, J., Budhu, A., Forgues, M., Yang, W., Wang, Y., Wang, X. W. (2010). NIH Public Access, 136(3), 1012\u20131024. doi: 10.1053\/j.gastro.2008.12.004.EpCAM-positive ."},{"key":"9574_CR47","doi-asserted-by":"crossref","unstructured":"L\u00f3pez, J., Valdez-Morales, F. J., Ben\u00edtez-Bribiesca, L., Cerb\u00f3n, M., & Carranc\u00e1, A. G. (2013). Normal and cancer stem cells of the human female reproductive system. Reproductive Biology and Endocrinology\u202f: RB&E, 11(Table 2), 53. 10.1186\/1477-7827-11-53","DOI":"10.1186\/1477-7827-11-53"},{"issue":"11","key":"9574_CR48","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1158\/0008-5472.CAN-10-3175","volume":"71","author":"IA Silva","year":"2011","unstructured":"Silva, I. A., Bai, S., McLean, K., Yang, K., Griffith, K., Thomas, D., & Buckanovich, R. J. (2011). Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Research, 71(11), 3991\u20134001. doi: 10.1158\/0008-5472.CAN-10-3175 .","journal-title":"Cancer Research"},{"key":"9574_CR49","author":"F Islam","year":"2015","unstructured":"Islam, F., Qiao, B., Smith, R. A., Gopalan, V., & Lam, A. K. Y. (2015). Cancer stem cell: Fundamental experimental pathological concepts and updates. Experimental and Molecular Pathology. doi: 10.1016\/j.yexmp.2015.02.002 .","journal-title":"Experimental and Molecular Pathology"},{"issue":"December 1996","key":"9574_CR50","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/(SICI)1097-0215(19970904)72:5<821::AID-IJC19>3.0.CO;2-B","volume":"72","author":"I Gorai","year":"1997","unstructured":"Gorai, I., Yanagibashi, T., Taki, A., Udagawa, K., Miyagi, E., Nakazawa, T., & Minaguchi, H. (1997). Uterine carcinosarcoma is derived from a single stem cell: an in vitro study. International Journal of Cancer, 72(December 1996), 821\u2013827. doi: 10.1002\/(SICI)1097-0215(19970904)72:5<821::AID-IJC19>3.0.CO;2-B .","journal-title":"International Journal of Cancer"},{"issue":"21","key":"9574_CR51","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1158\/0008-5472.CAN-08-4808","volume":"69","author":"SA Hubbard","year":"2009","unstructured":"Hubbard, S. A., Friel, A. M., Kumar, B., Zhang, L., Rueda, B. R., & Gargett, C. E. (2009). Evidence for cancer stem cells in human endometrial carcinoma. Cancer Research, 69(21), 8241\u20138248. doi: 10.1158\/0008-5472.CAN-08-4808 .","journal-title":"Cancer Research"},{"issue":"2","key":"9574_CR52","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4161\/cc.7.2.5207","volume":"7","author":"AM Friel","year":"2008","unstructured":"Friel, A. M., Sergent, P. A., Patnaude, C., Szotek, P. P., Oliva, E., Scadden, D. T., & Rueda, B. R. (2008). Functional analyses of the cancer stem cell-like properties of human endometrial tumor initiating cells. Cell Cycle, 7(2), 242\u2013249. doi: 10.4161\/cc.7.2.5207 .","journal-title":"Cell Cycle"},{"issue":"1","key":"9574_CR53","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2353\/ajpath.2010.090056","volume":"176","author":"K Kato","year":"2010","unstructured":"Kato, K., Takao, T., Kuboyama, A., Tanaka, Y., Ohgami, T., Yamaguchi, S., & Wake, N. (2010). Endometrial cancer side-population cells show prominent migration and have a potential to differentiate into the mesenchymal cell lineage. The American Journal of Pathology, 176(1), 381\u2013392. doi: 10.2353\/ajpath.2010.090056 .","journal-title":"The American Journal of Pathology"},{"key":"9574_CR54","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s13577-013-0079-2","volume":"27","author":"S Tomiyasu","year":"2014","unstructured":"Tomiyasu, S., Miyamoto, T., Mori, M., Yaguchi, T., Yakushiji, H., Ohno, S., & Ohno, E. (2014). Isolation of side population cells from endometrial cancer cells using a violet laser diode. Human Cell, 27, 36\u201342. doi: 10.1007\/s13577-013-0079-2 .","journal-title":"Human Cell"},{"issue":"8","key":"9574_CR55","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/ijc.25856","volume":"129","author":"M G\u00f6tte","year":"2011","unstructured":"G\u00f6tte, M., Greve, B., Kelsch, R., M\u00fcller-Uthoff, H., Weiss, K., Kharabi Masouleh, B., & Buchweitz, O. (2011). The adult stem cell marker Musashi-1 modulates endometrial carcinoma cell cycle progression and apoptosis via Notch-1 and p21WAF1\/CIP1. International Journal of Cancer, 129(8), 2042\u20132049. doi: 10.1002\/ijc.25856 .","journal-title":"International Journal of Cancer"},{"issue":"3","key":"9574_CR56","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/PGP.0b013e3182055a1f","volume":"30","author":"X Zhou","year":"2011","unstructured":"Zhou, X., Zhou, Y.-P., Huang, G.-R., Gong, B.-L., Yang, B., Zhang, D.-X., & Xu, S.-R. (2011). Expression of the stem cell marker, Nanog, in human endometrial adenocarcinoma. International Journal of Gynecological Pathology, 30(3), 262\u2013270. doi: 10.1097\/PGP.0b013e3182055a1f .","journal-title":"International Journal of Gynecological Pathology"},{"key":"9574_CR57","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nature06534","volume":"451","author":"I-H Park","year":"2008","unstructured":"Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., & Daley, G. Q. (2008). Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 451, 141\u2013146. doi: 10.1038\/nature06534 .","journal-title":"Nature"},{"issue":"17","key":"9574_CR58","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1002\/cncr.25944","volume":"117","author":"Y Wu","year":"2011","unstructured":"Wu, Y., Liu, S., Xin, H., Jiang, J., Younglai, E., Sun, S., & Wang, H. (2011). Up-regulation of microRNA-145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells. Cancer, 117(17), 3989\u20133998. doi: 10.1002\/cncr.25944 .","journal-title":"Cancer"},{"issue":"5","key":"9574_CR59","first-page":"1559","volume":"30","author":"A Honig","year":"2010","unstructured":"Honig, A., Weidler, C., H\u00e4usler, S., Krockenberger, M., Buchholz, S., K\u00f6ster, F., & Engel, J. B. (2010). Overexpression of polycomb protein BMI-1 in human specimens of breast, ovarian, endometrial and cervical cancer. Anticancer Research, 30(5), 1559\u20131564.","journal-title":"Anticancer Research"},{"key":"9574_CR60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1476-4598-10-99","volume":"10","author":"P Dong","year":"2011","unstructured":"Dong, P., Kaneuchi, M., Watari, H., Hamada, J., Sudo, S., Ju, J., & Sakuragi, N. (2011). MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1. Molecular Cancer, 10, 99. doi: 10.1186\/1476-4598-10-99 .","journal-title":"Molecular Cancer"},{"issue":"10","key":"9574_CR61","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/ncb2099","volume":"12","author":"M-H Yang","year":"2010","unstructured":"Yang, M.-H., Hsu, D. S.-S., Wang, H.-W., Wang, H.-J., Lan, H.-Y., Yang, W.-H., & Wu, K.-J. (2010). Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nature Cell Biology, 12(10), 982\u2013992. doi: 10.1038\/ncb2099 .","journal-title":"Nature Cell Biology"},{"key":"9574_CR62","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1186\/1471-2164-10-613","volume":"10","author":"S-J Chang","year":"2009","unstructured":"Chang, S.-J., Wang, T.-Y., Tsai, C.-Y., Hu, T.-F., Chang, M. D.-T., & Wang, H.-W. (2009). Increased epithelial stem cell traits in advanced endometrial endometrioid carcinoma. BMC Genomics, 10, 613. doi: 10.1186\/1471-2164-10-613 .","journal-title":"BMC Genomics"},{"issue":"10","key":"9574_CR63","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.humpath.2013.04.009","volume":"44","author":"C Mirantes","year":"2013","unstructured":"Mirantes, C., Espinosa, I., Ferrer, I., Dolcet, X., Prat, J., & Matias-Guiu, X. (2013). Epithelial-to-mesenchymal transition and stem cells in endometrial cancer. Human Pathology, 44(10), 1973\u20131981. doi: 10.1016\/j.humpath.2013.04.009 .","journal-title":"Human Pathology"},{"issue":"4","key":"9574_CR64","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/PGP.0b013e3182102754","volume":"30","author":"I Cervell\u00f3","year":"2011","unstructured":"Cervell\u00f3, I., Mirantes, C., Santamaria, X., Dolcet, X., Matias-Guiu, X., & Sim\u00f3n, C. (2011). Stem cells in human endometrium and endometrial carcinoma. International Journal of Gynecological Pathology, 30(4), 317\u2013327. doi: 10.1097\/PGP.0b013e3182102754 .","journal-title":"International Journal of Gynecological Pathology"},{"key":"9574_CR65","author":"P Dong","year":"2013","unstructured":"Dong, P., Kaneuchi, M., Konno, Y., Watari, H., Sudo, S., & Sakuragi, N. (2013). Emerging therapeutic biomarkers in endometrial cancer. BioMed Research International. doi: 10.1155\/2013\/130362 .","journal-title":"BioMed Research International"},{"key":"9574_CR66","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ygyno.2013.03.005","volume":"129","author":"S Kusunoki","year":"2013","unstructured":"Kusunoki, S., Kato, K., Tabu, K., Inagaki, T., Okabe, H., Kaneda, H., & Takeda, S. (2013). The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells. Gynecologic Oncology, 129, 598\u2013605. doi: 10.1016\/j.ygyno.2013.03.005 .","journal-title":"Gynecologic Oncology"},{"key":"9574_CR67","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ygyno.2014.04.009","volume":"134","author":"N Yusuf","year":"2014","unstructured":"Yusuf, N., Inagaki, T., Kusunoki, S., Okabe, H., Yamada, I., Matsumoto, A., & Kato, K. (2014). SPARC was overexpressed in human endometrial cancer stem-like cells and promoted migration activity. Gynecologic Oncology, 134, 356\u2013363. doi: 10.1016\/j.ygyno.2014.04.009 .","journal-title":"Gynecologic Oncology"},{"issue":"49","key":"9574_CR68","doi-asserted-by":"crossref","first-page":"17739","DOI":"10.1073\/pnas.0503976102","volume":"102","author":"JY Kim","year":"2005","unstructured":"Kim, J. Y., Tavar\u00e9, S., & Shibata, D. (2005). Counting human somatic cell replications: methylation mirrors endometrial stem cell divisions. Proceedings of the National Academy of Sciences of the United States of America, 102(49), 17739\u201317744. doi: 10.1073\/pnas.0503976102 .","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"9574_CR69","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1477-7827-8-147","volume":"8","author":"AM Friel","year":"2010","unstructured":"Friel, A. M., Zhang, L., Curley, M. D., Therrien, V. A., Sergent, P. A., Belden, S. E., & Rueda, B. R. (2010). Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells. Reproductive Biology and Endocrinology, 8(1), 147. doi: 10.1186\/1477-7827-8-147 .","journal-title":"Reproductive Biology and Endocrinology"},{"issue":"1","key":"9574_CR70","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12967-014-0231-0","volume":"12","author":"P Dong","year":"2014","unstructured":"Dong, P., Konno, Y., Watari, H., Hosaka, M., Noguchi, M., & Sakuragi, N. (2014). The impact of microRNA-mediated PI3K\/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer. Journal of Translational Medicine, 12(1), 231. doi: 10.1186\/s12967-014-0231-0 .","journal-title":"Journal of Translational Medicine"},{"issue":"2","key":"9574_CR71","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ygyno.2014.02.033","volume":"133","author":"X Zhou","year":"2014","unstructured":"Zhou, X., Gao, Q., Wang, J., Zhang, X., Liu, K., & Duan, Z. (2014). Linc-RNA-RoR acts as a \u201csponge\u201d against mediation of the differentiation of endometrial cancer stem cells by microRNA-145. Gynecologic Oncology, 133(2), 333\u2013339. doi: 10.1016\/j.ygyno.2014.02.033 .","journal-title":"Gynecologic Oncology"},{"issue":"2","key":"9574_CR72","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.febslet.2014.12.002","volume":"589","author":"Y Gao","year":"2015","unstructured":"Gao, Y., Liu, T., & Huang, Y. (2015). MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins. FEBS Letters, 589(2), 207\u2013214. doi: 10.1016\/j.febslet.2014.12.002 .","journal-title":"FEBS Letters"},{"issue":"15","key":"9574_CR73","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.18632\/oncotarget.2157","volume":"5","author":"Y Konno","year":"2014","unstructured":"Konno, Y., Dong, P., Xiong, Y., Suzuki, F., & Lu, J. (2014). MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells. Oncotarget, 5(15), 6049\u20136062.","journal-title":"Oncotarget"},{"key":"9574_CR74","doi-asserted-by":"crossref","unstructured":"Li, a, Jiao, Y., Yong, K. J., Wang, F., Gao, C., Yan, B., Chai, L. (2013). SALL4 is a new target in endometrial cancer. Oncogene, (November 2013), 1\u201310. doi: 10.1038\/onc.2013.529 .","DOI":"10.1038\/onc.2013.529"},{"issue":"5","key":"9574_CR75","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","volume":"1","author":"C Ginestier","year":"2007","unstructured":"Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., & Dontu, G. (2007). ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell, 1(5), 555\u2013567. doi: 10.1016\/j.stem.2007.08.014 .","journal-title":"Cell Stem Cell"},{"issue":"4","key":"9574_CR76","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1349-7006.2011.01864.x","volume":"102","author":"N Rahadiani","year":"2011","unstructured":"Rahadiani, N., Ikeda, J., Mamat, S., Matsuzaki, S., Ueda, Y., Umehara, R., & Morii, E. (2011). Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid adenocarcinoma and its clinical implications. Cancer Science, 102(4), 903\u2013908. doi: 10.1111\/j.1349-7006.2011.01864.x .","journal-title":"Cancer Science"},{"issue":"10","key":"9574_CR77","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1177\/1947601911436009","volume":"2","author":"S Mamat","year":"2011","unstructured":"Mamat, S., Ikeda, J.-I., Tian, T., Wang, Y., Luo, W., Aozasa, K., & Morii, E. (2011). Transcriptional regulation of aldehyde dehydrogenase 1A1 gene by alternative spliced forms of nuclear factor Y in tumorigenic population of endometrial adenocarcinoma. Genes & Cancer, 2(10), 979\u2013984. doi: 10.1177\/1947601911436009 .","journal-title":"Genes & Cancer"},{"key":"9574_CR78","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.2283","volume":"214","author":"D Mizrak","year":"2008","unstructured":"Mizrak, D., Brittan, M., & Alison, M. R. (2008). CD133: molecule of the moment. The Journal of Pathology, 214, 3\u20139. doi: 10.1002\/path.2283 .","journal-title":"The Journal of Pathology"},{"issue":"13","key":"9574_CR79","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1158\/1078-0432.CCR-08-1883","volume":"15","author":"S Rutella","year":"2009","unstructured":"Rutella, S., Bonanno, G., Procoli, A., Mariotti, A., Corallo, M., Prisco, M. G., & Ferrandina, G. (2009). Cells with characteristics of cancer stem\/progenitor cells express the CD133 antigen in human endometrial tumors. Clinical Cancer Research, 15(13), 4299\u20134311. doi: 10.1158\/1078-0432.CCR-08-1883 .","journal-title":"Clinical Cancer Research"},{"issue":"11","key":"9574_CR80","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.humpath.2010.05.006","volume":"41","author":"M Nakamura","year":"2010","unstructured":"Nakamura, M., Kyo, S., Zhang, B., Zhang, X., Mizumoto, Y., Takakura, M., & Inoue, M. (2010). Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer. Human Pathology, 41(11), 1516\u20131529. doi: 10.1016\/j.humpath.2010.05.006 .","journal-title":"Human Pathology"},{"issue":"2","key":"9574_CR81","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ygyno.2014.06.003","volume":"134","author":"WM Burke","year":"2014","unstructured":"Burke, W. M., Orr, J., Leitao, M., Salom, E., Gehrig, P., Olawaiye, A. B., & Shahin, F. A. (2014). Endometrial cancer: a review and current management strategies: part II. Gynecologic Oncology, 134(2), 393\u2013402. doi: 10.1016\/j.ygyno.2014.06.003 .","journal-title":"Gynecologic Oncology"},{"key":"9574_CR82","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/1479-7364-3-3-281","volume":"3","author":"V Vasiliou","year":"2009","unstructured":"Vasiliou, V., Vasiliou, K., & Nebert, D. W. (2009). Human ATP-binding cassette (ABC) transporter family. Human Genomics, 3, 281\u2013290. doi: 10.1186\/1479-7364-3-3-281 .","journal-title":"Human Genomics"},{"key":"9574_CR83","author":"M Cojoc","year":"2014","unstructured":"Cojoc, M., M\u00e4bert, K., Muders, M. H., & Dubrovska, A. (2014). A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms. Seminars in Cancer Biology. doi: 10.1016\/j.semcancer.2014.06.004 .","journal-title":"Seminars in Cancer Biology"},{"issue":"303","key":"9574_CR84","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2012.11.010","volume":"56","author":"S Singh","year":"2013","unstructured":"Singh, S., Brocker, C., Koppaka, V., Chen, Y., Jackson, B. C., Matsumoto, A., & Vasiliou, V. (2013). Aldehyde dehydrogenases in cellular responses to oxidative\/electrophilic stress. Free Radical Biology & Medicine, 56(303), 89\u2013101. doi: 10.1016\/j.freeradbiomed.2012.11.010 .","journal-title":"Free Radical Biology & Medicine"},{"issue":"39","key":"9574_CR85","doi-asserted-by":"crossref","first-page":"14228","DOI":"10.1073\/pnas.0400067101","volume":"101","author":"C Hirschmann-Jax","year":"2004","unstructured":"Hirschmann-Jax, C., Foster, A. E., Wulf, G. G., Nuchtern, J. G., Jax, T. W., Gobel, U., & Brenner, M. K. (2004). A distinct \u201cside population\u201d of cells with high drug efflux capacity in human tumor cells. Proceedings of the National Academy of Sciences of the United States of America, 101(39), 14228\u201314233. doi: 10.1073\/pnas.0400067101 .","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"April","key":"9574_CR86","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc1590","volume":"5","author":"M Dean","year":"2005","unstructured":"Dean, M., Fojo, T., & Bates, S. (2005). Tumour stem cells and drug resistance. Nature Reviews Cancer, 5(April), 275\u2013284. doi: 10.1038\/nrc1590 .","journal-title":"Nature Reviews Cancer"},{"issue":"3","key":"9574_CR87","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/1933719113497281","volume":"21","author":"L Chen","year":"2013","unstructured":"Chen, L., Chang, W.-C., Hung, Y.-C., Chang, Y.-Y., Bao, B.-Y., Huang, H.-C., & Ma, W.-L. (2013). Androgen receptor increases CD133 expression and progenitor-like population that associate with cisplatin resistance in endometrial cancer cell line. Reproductive Sciences (Thousand Oaks, Calif.), 21(3), 386\u2013394. doi: 10.1177\/1933719113497281 .","journal-title":"Reproductive Sciences (Thousand Oaks, Calif.)"},{"issue":"6","key":"9574_CR88","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.3892\/ijo.2014.2362","volume":"44","author":"S Li","year":"2014","unstructured":"Li, S., & Li, Q. (2014). Cancer stem cells and tumor metastasis (Review). International Journal of Oncology, 44(6), 1806\u201312. doi: 10.3892\/ijo.2014.2362 .","journal-title":"International Journal of Oncology"},{"issue":"18","key":"9574_CR89","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.1158\/0008-5472.CAN-09-0167","volume":"69","author":"C Folkins","year":"2009","unstructured":"Folkins, C., Shaked, Y., Man, S., Tang, T., Lee, C. R., Zhu, Z., & Kerbel, R. S. (2009). Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1. Cancer Research, 69(18), 7243\u20137251. doi: 10.1158\/0008-5472.CAN-09-0167 .","journal-title":"Cancer Research"},{"issue":"2","key":"9574_CR90","first-page":"46","volume":"3","author":"WWW Liao","year":"2014","unstructured":"Liao, W. W. W., Ye, Y. Y., Deng, Y. Y., Bian, X. X., & Ding, Y. Y. (2014). Metastatic cancer stem cells : from the concept to therapeutics. Americam Journal of Stem Cells, 3(2), 46\u201362.","journal-title":"Americam Journal of Stem Cells"},{"key":"9574_CR91","doi-asserted-by":"crossref","unstructured":"Alonso-alconada, L., Muinelo-Romay, L., Madissoo, K., Diaz-lopez, A., Krakstad, C., Trovik, J., Romano, A. (2014). Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer, 1\u201310.","DOI":"10.1186\/1476-4598-13-223"},{"issue":"5","key":"9574_CR92","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrclinonc.2010.216","volume":"8","author":"KJ Dedes","year":"2011","unstructured":"Dedes, K. J., Wetterskog, D., Ashworth, A., Kaye, S. B., & Reis-Filho, J. S. (2011). Emerging therapeutic targets in endometrial cancer. Nature reviewsClinical Oncology, 8(5), 261\u2013271. doi: 10.1038\/nrclinonc.2010.216 .","journal-title":"Nature reviewsClinical Oncology"},{"issue":"August","key":"9574_CR93","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1158\/1535-7163.MCT-10-1062","volume":"10","author":"K Kato","year":"2011","unstructured":"Kato, K., Kuhara, A., Yoneda, T., Inoue, T., Takao, T., Ohgami, T., & Wake, N. (2011). Sodium butyrate inhibits the self-renewal capacity of endometrial tumor side-population cells by inducing a DNA damage response. Molecular Cancer Therapeutics, 10(August), 1430\u20131439. doi: 10.1158\/1535-7163.MCT-10-1062 .","journal-title":"Molecular Cancer Therapeutics"},{"key":"9574_CR94","author":"M Vanneman","year":"2012","unstructured":"Vanneman, M., & Dranoff, G. (2012). Combining immunotherapy and targeted therapies in cancer treatment. Nature Reviews Cancer. doi: 10.1038\/nrc3237 .","journal-title":"Nature Reviews Cancer"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-015-9574-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10555-015-9574-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-015-9574-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T16:58:56Z","timestamp":1567011536000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10555-015-9574-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,30]]},"references-count":94,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["9574"],"URL":"https:\/\/doi.org\/10.1007\/s10555-015-9574-0","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,30]]}}}